Nanoparticle technology created by researchers at the University of Washington School of Medicine is featured in a vaccine for respiratory syncytial virus (commonly known as RSV).
A study just underway at UW Medicine is evaluating whether a lab-formulated monoclonal antibody could curb the over-amplified inflammatory response that some patients experience with COVID-19 pneumonia. The researchers are evaluating the drug's
Pregnant women, especially in their last trimester, need to be very guarded to avoid contracting COVID-19, according to new statewide data collected by a group of obstetricians across several hospital systems in Washington.
